Now showing items 1-3 of 3

    • Clinical phenotypes in sarcoidosis 

      Pereira, Carlos A. C. [UNIFESP]; Dornfeld, Marina C. [UNIFESP]; Baughman, Robert; Judson, Marc A. (Lippincott Williams & Wilkins, 2014-09-01)
      Purpose of reviewTo describe the methods for derivation of clinical phenotypes in general and how they should be applied in sarcoidosis, taking into account the dimensions of the disease. the results from the small number ...

    • Factor analysis of sarcoidosis phenotypes at two referral centers in Brazil 

      Rodrigues, S. C. S. [UNIFESP]; Rocha, N. A. S.; Lima, M. S.; Arakaki, J. S. O. [UNIFESP]; Coletta, E. N. A. [UNIFESP]; Ferreira, R. G. [UNIFESP]; Gonzaga, L. R. [UNIFESP]; Pereira, C. A. C. [UNIFESP] (Fondazione Pneumologia U I P Onlus, 2011-07-01)
      Background: In sarcoidosis, clinical presentations and outcomes vary widely. Objective: To characterize the clinical phenotypes of sarcoidosis, by factor analysis, in a series of cases with long-term follow-up. Methods: ...

    • Prevalence of mutations related to HIV-1 antiretroviral resistance in Brazilian patients failing HAART 

      Tanuri, A.; Caridea, E.; Dantas, M. C.; Morgado, M. G.; Mello, DLC; Borges, S.; Tavares, M.; Ferreira, S. B.; Santoro-Lopes, G.; Martins, CRF; Esteves, ALC; Diaz, R. S.; Andreo, SMS; Ferreira, LAP; Rodrigues, R.; Reuter, T.; Cavalcanti, AMS; Oliveira, S. M. de; Barbosa, H. B. de; Teixeira, P. R.; Chequer, P. N. (Elsevier B.V., 2002-07-01)
      Background: Current guidelines for antiretroviral (ARV) therapy recommend at least triple-drug combination, the so-called highly active antiretroviral therapy (HAART). Not all patients respond to HAART and the development ...